194 related articles for article (PubMed ID: 32994401)
41. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
[TBL] [Abstract][Full Text] [Related]
42. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
Cacabelos R
Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
[TBL] [Abstract][Full Text] [Related]
43. Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case-control study.
Steele NZ; Carr JS; Bonham LW; Geier EG; Damotte V; Miller ZA; Desikan RS; Boehme KL; Mukherjee S; Crane PK; Kauwe JS; Kramer JH; Miller BL; Coppola G; Hollenbach JA; Huang Y; Yokoyama JS
PLoS Med; 2017 Mar; 14(3):e1002272. PubMed ID: 28350795
[TBL] [Abstract][Full Text] [Related]
44. Long-Lived Individuals Show a Lower Burden of Variants Predisposing to Age-Related Diseases and a Higher Polygenic Longevity Score.
Torres GG; Dose J; Hasenbein TP; Nygaard M; Krause-Kyora B; Mengel-From J; Christensen K; Andersen-Ranberg K; Kolbe D; Lieb W; Laudes M; Görg S; Schreiber S; Franke A; Caliebe A; Kuhlenbäumer G; Nebel A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142858
[TBL] [Abstract][Full Text] [Related]
45. Liver-Specific Polygenic Risk Score Is Associated with Alzheimer's Disease Diagnosis.
Panyard DJ; Deming YK; Darst BF; Van Hulle CA; Zetterberg H; Blennow K; Kollmorgen G; Suridjan I; Carlsson CM; Johnson SC; Asthana S; Engelman CD; Lu Q
J Alzheimers Dis; 2023; 92(2):395-409. PubMed ID: 36744333
[TBL] [Abstract][Full Text] [Related]
46. Longitudinal Maintenance of Cognitive Health in Centenarians in the 100-plus Study.
Beker N; Sikkes SAM; Hulsman M; Tesi N; van der Lee SJ; Scheltens P; Holstege H
JAMA Netw Open; 2020 Feb; 3(2):e200094. PubMed ID: 32101309
[TBL] [Abstract][Full Text] [Related]
47. Identifying the Main Functional Pathways Associated with Cognitive Resilience to Alzheimer's Disease.
Pérez-González M; Badesso S; Lorenzo E; Guruceaga E; Pérez-Mediavilla A; García-Osta A; Cuadrado-Tejedor M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502030
[TBL] [Abstract][Full Text] [Related]
48. Polygenic risk for Alzheimer's disease is not associated with cognitive ability or cognitive aging in non-demented older people.
Harris SE; Davies G; Luciano M; Payton A; Fox HC; Haggarty P; Ollier W; Horan M; Porteous DJ; Starr JM; Whalley LJ; Pendleton N; Deary IJ
J Alzheimers Dis; 2014; 39(3):565-74. PubMed ID: 24246418
[TBL] [Abstract][Full Text] [Related]
49. A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease.
Porter T; Burnham SC; Savage G; Lim YY; Maruff P; Milicic L; Peretti M; Ames D; Masters CL; Martins RN; Rainey-Smith S; Rowe CC; Salvado O; Taddei K; Groth D; Verdile G; Villemagne VL; Laws SM
Front Aging Neurosci; 2018; 10():423. PubMed ID: 30620773
[TBL] [Abstract][Full Text] [Related]
50. Genetic Association Between Epigenetic Aging-Acceleration and the Progression of Mild Cognitive Impairment to Alzheimer's Disease.
Liu H; Lutz M; Luo S;
J Gerontol A Biol Sci Med Sci; 2022 Sep; 77(9):1734-1742. PubMed ID: 35797594
[TBL] [Abstract][Full Text] [Related]
51. APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease.
Konijnenberg E; Tijms BM; Gobom J; Dobricic V; Bos I; Vos S; Tsolaki M; Verhey F; Popp J; Martinez-Lage P; Vandenberghe R; Lleó A; Frölich L; Lovestone S; Streffer J; Bertram L; Blennow K; Teunissen CE; Veerhuis R; Smit AB; Scheltens P; Zetterberg H; Visser PJ
Alzheimers Res Ther; 2020 May; 12(1):65. PubMed ID: 32460813
[TBL] [Abstract][Full Text] [Related]
52. Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.
Desikan RS; Fan CC; Wang Y; Schork AJ; Cabral HJ; Cupples LA; Thompson WK; Besser L; Kukull WA; Holland D; Chen CH; Brewer JB; Karow DS; Kauppi K; Witoelar A; Karch CM; Bonham LW; Yokoyama JS; Rosen HJ; Miller BL; Dillon WP; Wilson DM; Hess CP; Pericak-Vance M; Haines JL; Farrer LA; Mayeux R; Hardy J; Goate AM; Hyman BT; Schellenberg GD; McEvoy LK; Andreassen OA; Dale AM
PLoS Med; 2017 Mar; 14(3):e1002258. PubMed ID: 28323831
[TBL] [Abstract][Full Text] [Related]
53. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
[TBL] [Abstract][Full Text] [Related]
54. Mapping the genetic landscape of early-onset Alzheimer's disease in a cohort of 36 families.
Mol MO; van der Lee SJ; Hulsman M; Pijnenburg YAL; Scheltens P; ; Seelaar H; van Swieten JC; Kaat LD; Holstege H; van Rooij JGJ
Alzheimers Res Ther; 2022 Jun; 14(1):77. PubMed ID: 35650585
[TBL] [Abstract][Full Text] [Related]
55. Association of the CD2AP locus with cognitive functioning among middle-aged individuals with a family history of Alzheimer's disease.
Manzali SB; Ravona-Springer R; Alkelai A; Yu E; Gan-Or Z; Ganmore I; Heymann A; Beeri MS; Greenbaum L
Neurobiol Aging; 2021 May; 101():50-56. PubMed ID: 33578194
[TBL] [Abstract][Full Text] [Related]
56. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.
van der Lee SJ; Wolters FJ; Ikram MK; Hofman A; Ikram MA; Amin N; van Duijn CM
Lancet Neurol; 2018 May; 17(5):434-444. PubMed ID: 29555425
[TBL] [Abstract][Full Text] [Related]
57. Genetic perturbations of disease risk genes in mice capture transcriptomic signatures of late-onset Alzheimer's disease.
Pandey RS; Graham L; Uyar A; Preuss C; Howell GR; Carter GW
Mol Neurodegener; 2019 Dec; 14(1):50. PubMed ID: 31878951
[TBL] [Abstract][Full Text] [Related]
58. Alzheimer's Disease Polygenic Risk Score Is Not Associated With Cognitive Decline Among Older Adults With Type 2 Diabetes.
Manzali SB; Yu E; Ravona-Springer R; Livny A; Golan S; Ouyang Y; Lesman-Segev O; Liu L; Ganmore I; Alkelai A; Gan-Or Z; Lin HM; Heymann A; Schnaider Beeri M; Greenbaum L
Front Aging Neurosci; 2022; 14():853695. PubMed ID: 36110429
[TBL] [Abstract][Full Text] [Related]
59. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
60. Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer's disease.
Yokoyama JS; Bonham LW; Sears RL; Klein E; Karydas A; Kramer JH; Miller BL; Coppola G
BMC Neurol; 2015 Mar; 15():47. PubMed ID: 25880661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
